CorporateSun Pharma Gets Ratings Boost From Moody's, S&P Over $11.75-Bn Organon & Co Acquisition BidBY PTI
CorporateSun Pharma–Organon Deal: Where Does It Rank in the List of Outgoing Acquisitions?BY Outlook Business Desk
CorporateSun Pharma Partners With Royal Challengers Bengaluru As Principal Sponsor For 3-Year PeriodBY PTI
CorporateGautam Adani, Mukesh Ambani Among Billionaires Hit by Stock Market Slump| Full List HereBY Outlook Business Desk
